Stopping Cancer Early – The Best Possible Investment


Posts Tagged ‘Fundraising’

The Founder’s Fund

May 15, 2012

Silicon Valley is famous for its ability to take an existing idea or product and revolutionize it, making it better, cheaper, and more accessible to the public.

Canary Foundation’s Founder, Don Listwin, took passionately to bringing this approach to the flailing and antiquated health care business, which invested little in cancer early detection. Most of our community members are familiar with Don’s emotional story of losing his mother to misdiagnosed cancer. His story is a testament to the scars cancer leaves on all of our lives, as well as the power of people coming together to fund something that will have a lasting impact—impact on the future of cancer early detection, and on the lives of our loved ones.

A seasoned technology executive, Don established a plan to catalyze cancer early detection. He founded Canary Foundation to bridge the gap between academic research and an industry that no longer actively invests in early detection research. Our goal is to leverage the research we do in developing biomarkers and imaging technology to create widely accessible tests that screen for cancer, even during routine checkups.

By approaching health care technology with the same results-driven mindset as consumer technology, Canary Foundation is changing the game for early detection research and innovation. Investing early in innovation and attracting other funding exemplifies the high impact model Don built at Canary. Staying true to the model, we pool expertise, focus on results, and stay conscious about resource allocation.

Canary Foundation’s Founder’s Fund takes this last idea to heart. The Founder’s Fund is a special reserve that allows for Canary Foundation to fund special projects, communications and events and unmet needs that keep Canary on task to make cancer early detection a reality. We invite you to learn more about the Founder’s Fund and join others in supporting the Canary mission.

Rally Your Team for the Canary Challenge!

March 8, 2012

Dr. Fred Chin, Head of Cyclotron Radiochemistry at Stanford University Medical Center & Canary Challenge Rider, extends his passion for early cancer detection research beyond the lab, fundraising and promoting awareness through his participation in the Canary Challenge. He shares his motivation for creating and leading “Team MIPS” (Molecular Imaging Program at Stanford), leveraging the opportunity to bond and build relationships with other researchers and physicians on the team. Watch this short video to learn more about Fred’s experience, goals, and words of wisdom for new riders.


Funds raised in 2012 Canary Challenge will be donated to the Stanford Cancer Institute (SCI) to benefit cancer research and innovative supportive care programs. Cancer strikes about one in three women and one in two men in the United States. Canary Foundation, the producer of the event, is committed to identifying early stage cancers to save lives.

To register for the Canary Challenge, visit: